Global Microbiology Testing Market Opportunities and Forecast 2023-2030
- DLR2174
- 19 September, 2020
- Pharma & Healthcare
- Pages: 120
- Global
Global Microbiology Testing Market, By Products (Instruments and Reagents), By Disease Area (Respiratory Diseases, Bloodstream infections, Gastrointestinal Diseases, STDs, urinary Tract Infections), By Application (Pharmaceutical, Clinical, Food Testing) opportunities and forecast 2023-2030
Market Overview
Microbial testing is an analytical technique utilized to determine a number of microorganisms in food, beverages, biological samples, and environmental samples. The microbial testing technique employs chemical, biological, biochemical, or molecular methods to identify and quantify microbes. The growth of the global microbial testing market is driven by an increase in the prevalence of various infectious diseases and surge in outbreaks of epidemics. Moreover, the growing healthcare expenditure globally and increased research funding are expected to boost the market growth. However, a stringent regulatory framework and patient reimbursement situations are anticipated to impede the market growth. Moreover, the market growth of microbiology testing is at threat from erroneous results and the high cost of reagents and instruments. However, increase in R&D activities coupled with grants for the same is expected to provide opportunities for market growth. However, tightened government regulations and policies are likely to remain as challenges to market growth.
Growing demand for point-of-care (POC) diagnostics is the latest trend being observed in the microbiology testing market. Moreover, strategic planning by the compnies to attain more market share are further expected to propel the market growt in the coming years. For Instance in August 2018, Neogen Corporation, an international food safety company, announced the acquisition of Clarus Labs, Inc. The acquisition includes the patented Colitag water test.
Segment Overview
Based on application, food industry is expected to dominate the market of global microbiology market. The industry generates continual demand for microbiological testing. Ensuring food safety is of paramount importance in the food industry. Food manufacturers incur huge economic losses due to contamination and spoilage from bacteria. Moreover, regulatory bodies mandate microbiological testing of food items before it is put up for sale in the market. Food manufacturers extensively utilize microbiological testing to quantify and detect pathogenic spoilage and microorganisms.
Regional Overview
Geographically, the global microbiology testing market is divided into five regions - North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North-America holds the largest market share in terms of revenue followed by Europe. Rising prevalence of various diseases among the population, refined healthcare infrastructure, and rising need for advanced diagnostic testing are the key reasons accounted for the market growth in North America. Developing economies of Asia Pacific and Latin America such as India, China, and Brazil are expected to experience a rapid expansion due to favorable laws being incorporated in the country, tax benefits, favorable reimbursement scenario, and increasing medical tourism in these nations. Moreover, the rise in prevalence and severity of diseases in emerging nations such as India, China, Indonesia, and Malaysia propels the growth in the region.
Competitor overview
Key players involved in the global microbiology testing markets are Bio-Rad Laboratories, Becton Dickinson and Company, Danaher, bioMérieux, and Thermo Fisher Scientific. Other prominent vendors are Abbott Diagnostics, Alcon Laboratories, Cepheid, Cavidi, and many more.
February 2019 – bioMérieux, Inc., a global leader in in-vitro diagnostics, offering microbiological testing solutions for medical applications, has announced the acquisition of Invisible Sentinel, developer, manufacturer, and marketer of molecular diagnostic tool. The acquisition will help bioMérieux strengthen its position in food pathogen testing and spoilage organism detection segment.
Key Players
Market Segmentation
By Products
Market Overview
Microbial testing is an analytical technique utilized to determine a number of microorganisms in food, beverages, biological samples, and environmental samples. The microbial testing technique employs chemical, biological, biochemical, or molecular methods to identify and quantify microbes. The growth of the global microbial testing market is driven by an increase in the prevalence of various infectious diseases and surge in outbreaks of epidemics. Moreover, the growing healthcare expenditure globally and increased research funding are expected to boost the market growth. However, a stringent regulatory framework and patient reimbursement situations are anticipated to impede the market growth. Moreover, the market growth of microbiology testing is at threat from erroneous results and the high cost of reagents and instruments. However, increase in R&D activities coupled with grants for the same is expected to provide opportunities for market growth. However, tightened government regulations and policies are likely to remain as challenges to market growth.
Growing demand for point-of-care (POC) diagnostics is the latest trend being observed in the microbiology testing market. Moreover, strategic planning by the compnies to attain more market share are further expected to propel the market growt in the coming years. For Instance in August 2018, Neogen Corporation, an international food safety company, announced the acquisition of Clarus Labs, Inc. The acquisition includes the patented Colitag water test.
Segment Overview
Based on application, food industry is expected to dominate the market of global microbiology market. The industry generates continual demand for microbiological testing. Ensuring food safety is of paramount importance in the food industry. Food manufacturers incur huge economic losses due to contamination and spoilage from bacteria. Moreover, regulatory bodies mandate microbiological testing of food items before it is put up for sale in the market. Food manufacturers extensively utilize microbiological testing to quantify and detect pathogenic spoilage and microorganisms.
Regional Overview
Geographically, the global microbiology testing market is divided into five regions - North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North-America holds the largest market share in terms of revenue followed by Europe. Rising prevalence of various diseases among the population, refined healthcare infrastructure, and rising need for advanced diagnostic testing are the key reasons accounted for the market growth in North America. Developing economies of Asia Pacific and Latin America such as India, China, and Brazil are expected to experience a rapid expansion due to favorable laws being incorporated in the country, tax benefits, favorable reimbursement scenario, and increasing medical tourism in these nations. Moreover, the rise in prevalence and severity of diseases in emerging nations such as India, China, Indonesia, and Malaysia propels the growth in the region.
Competitor overview
Key players involved in the global microbiology testing markets are Bio-Rad Laboratories, Becton Dickinson and Company, Danaher, bioMérieux, and Thermo Fisher Scientific. Other prominent vendors are Abbott Diagnostics, Alcon Laboratories, Cepheid, Cavidi, and many more.
February 2019 – bioMérieux, Inc., a global leader in in-vitro diagnostics, offering microbiological testing solutions for medical applications, has announced the acquisition of Invisible Sentinel, developer, manufacturer, and marketer of molecular diagnostic tool. The acquisition will help bioMérieux strengthen its position in food pathogen testing and spoilage organism detection segment.
Key Players
- Bio-Rad Laboratories
- Becton Dickinson and Company
- Danaher
- bioMérieux
- Thermo Fisher Scientific
- Abbott Diagnostics
- Alcon Laboratories
- Cepheid
- Cavidi
Market Segmentation
By Products
- Instruments
- Laboratory Instruments
- Microbiology Analysers
- Reagents
- Respiratory diseases
- Bloodstream infections
- Periodontal diseases
- Gastrointestinal diseases
- Urinary tract infections
- Sexually transmitted diseases
- Other diseases
- Pharmaceutical
- Food Testing
- Clinical
- Energy
- Environment
- Chemical and Material Manufacturing
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- UAE
- Rest of LAMEA
1 Report Prologue 11
2 Introduction 14
- 2.1 Scope of Study 14
- 2.2 Research Objective 14
- 2.3 Assumptions & Limitations 15
- 2.3.1 Assumptions 15
- 2.3.2 Limitations 15
3 Research Methodology 16
- 3.1 Research Process 16
- 3.2 Primary Research 17
- 3.3 Secondary Research 17
4 Market Dynamics 19
- 4.1 Introduction 19
- 4.2 Drivers 20
- 4.2.1 Technological Advancements 20
- 4.2.2 Rising Cases of Infectious Diseases 20
- 4.2.3 Surveillance Programs for Disease Control 20
- 4.2.4 Rising Stringency of Standards 20
- 4.2.5 Weakness of Traditional Laboratory Techniques 21
- 4.3 Restraints 21
- 4.3.1 Erroneous results 21
- 4.3.2 High cost of reagents and instruments 21
- 4.4 Opportunities 21
- 4.4.1 Research and Development 21
- 4.4.2 Rising Grants, Collaborations and Partnerships 22
- 4.5 Challenges 22
- 4.5.1 Government regulations and policies 22
5 Market Factor Analysis 23
- 5.1 Porters Five Forces Analysis 23
- 5.1.1 Bargaining Power of Suppliers 24
- 5.1.2 Bargaining Power of Buyers 24
- 5.1.3 Threat of New Entrants 24
- 5.1.4 Threat of Substitutes 24
- 5.1.5 Intensity of Rivalry 25
- 5.2 Supply Chain Analysis 25
- 5.3 Value Chain Analysis 26
- 5.3.1 Primary activities 26
- 5.3.2 Secondary Activities 26
6 Global Microbiology Testing Market, By Product Type 28
- 6.1 Introduction 28
7 Global Microbiology Testing Market, By Application 33
- 7.1 Introduction 33
8 Global Microbiology Testing Market, By End User 37
9 Global Microbiology Testing Market, By Region 41
- 9.1 North America 43
- 9.1.1 Canada 49
- 9.1.2 US 51
- 9.2 Europe 53
- 9.2.1 France 58
- 9.2.2 Germany 60
- 9.2.3 Italy 62
- 9.2.4 Spain 64
- 9.2.5 UK 66
- 9.2.6 Rest of Europe 68
- 9.3 Asia-Pacific (APAC) 70
- 9.3.1 Australia 76
- 9.3.2 China 78
- 9.3.3 Japan 80
- 9.3.4 Republic of South Korea 82
- 9.3.5 India 84
- 9.3.6 Rest of Asia-Pacific 86
- 9.4 Middle East and Africa (ME&A) 88
- 9.4.1 UAE 94
- 9.4.2 Saudi Arabia 96
- 9.4.3 Egypt 98
- 9.4.4 Rest of Middle East and Africa 100
10 Competitive Landscape 102
- 10.1 Market Share Analysis 102
11 Company Profile 103
- 11.1 Alere 103
- 11.1.1 Company Overview 103
- 11.1.2 Product Overview 103
- 11.1.3 Key Developments 104
- 11.1.4 Financials 104
- 11.1.5 SWOT Analysis 106
- 11.2 BD 107
- 11.2.1 Overview 107
- 11.2.2 Product Overview 107
- 11.2.3 Financials 108
- 11.2.4 Key Developments 109
- 11.2.5 SWOT Analysis 110
- 11.3 Beckman Coulter, Inc. (a subsidiary of Danaher Corp) 111
- 11.3.1 Company Overview 111
- 11.3.2 Product Overview 111
- 11.3.3 Financials 112
- 11.3.4 Key Developments 113
- 11.3.5 SWOT Analysis 114
- 11.4 Biomérieux SA 115
- 11.4.1 Company Overview 115
- 11.4.2 Product Overview 115
- 11.4.3 Financials 115
- 11.4.4 Key Developments 116
- 11.4.5 SWOT Analysis 117
- 11.5 Cepheid (a subsidiary of Danaher) 118
- 11.5.1 Company Overview 118
- 11.5.2 Product Overview 118
- 11.5.3 Financials 119
- 11.5.4 Key Developments 119
- 11.5.5 SWOT Analysis 120
- 11.6 F. Hoffmann-La Roche Ltd 121
- 11.6.1 Overview 121
- 11.6.2 Product/Business Segment Overview 121
- 11.6.3 Financial Updates 122
- 11.6.4 Key Developments 124
- 11.6.5 SWOT Analysis 124
- 11.7 Thermo Fisher Scientific Inc. 125
- 11.7.1 Product/Business Segment Overview 125
- 11.7.2 Financials 126
- 11.7.3 Key Developments 127
- 11.7.4 SWOT Analysis 128
Report You Might be Interested
Choose License Type
- USD
- GBP
- EURO
- INR
